Author Correction: Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE
- PMID: 32393781
- PMCID: PMC7214457
- DOI: 10.1038/s41598-020-65138-2
Author Correction: Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum for
-
Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE.Sci Rep. 2018 Mar 15;8(1):4649. doi: 10.1038/s41598-018-22867-9. Sci Rep. 2018. PMID: 29545630 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
